389 related articles for article (PubMed ID: 16567391)
1. CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer.
Wang D; Wang H; Brown J; Daikoku T; Ning W; Shi Q; Richmond A; Strieter R; Dey SK; DuBois RN
J Exp Med; 2006 Apr; 203(4):941-51. PubMed ID: 16567391
[TBL] [Abstract][Full Text] [Related]
2. Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer.
Keane MP; Belperio JA; Xue YY; Burdick MD; Strieter RM
J Immunol; 2004 Mar; 172(5):2853-60. PubMed ID: 14978086
[TBL] [Abstract][Full Text] [Related]
3. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis.
Numasaki M; Watanabe M; Suzuki T; Takahashi H; Nakamura A; McAllister F; Hishinuma T; Goto J; Lotze MT; Kolls JK; Sasaki H
J Immunol; 2005 Nov; 175(9):6177-89. PubMed ID: 16237115
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
5. CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer.
Matsuo Y; Raimondo M; Woodward TA; Wallace MB; Gill KR; Tong Z; Burdick MD; Yang Z; Strieter RM; Hoffman RM; Guha S
Int J Cancer; 2009 Sep; 125(5):1027-37. PubMed ID: 19431209
[TBL] [Abstract][Full Text] [Related]
6. Cell surface heparan sulfate participates in CXCL1-induced signaling.
Wang D; Sai J; Richmond A
Biochemistry; 2003 Feb; 42(4):1071-7. PubMed ID: 12549928
[TBL] [Abstract][Full Text] [Related]
7. Bcl-2 acts in a proangiogenic signaling pathway through nuclear factor-kappaB and CXC chemokines.
Karl E; Warner K; Zeitlin B; Kaneko T; Wurtzel L; Jin T; Chang J; Wang S; Wang CY; Strieter RM; Nunez G; Polverini PJ; Nör JE
Cancer Res; 2005 Jun; 65(12):5063-9. PubMed ID: 15958549
[TBL] [Abstract][Full Text] [Related]
8. IL-8/CXCL8 and growth-related oncogene alpha/CXCL1 induce chondrocyte hypertrophic differentiation.
Merz D; Liu R; Johnson K; Terkeltaub R
J Immunol; 2003 Oct; 171(8):4406-15. PubMed ID: 14530367
[TBL] [Abstract][Full Text] [Related]
9. CXCL1/macrophage inflammatory protein-2-induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth factor-A.
Scapini P; Morini M; Tecchio C; Minghelli S; Di Carlo E; Tanghetti E; Albini A; Lowell C; Berton G; Noonan DM; Cassatella MA
J Immunol; 2004 Apr; 172(8):5034-40. PubMed ID: 15067085
[TBL] [Abstract][Full Text] [Related]
10. Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis.
Caunt M; Hu L; Tang T; Brooks PC; Ibrahim S; Karpatkin S
Cancer Res; 2006 Apr; 66(8):4125-32. PubMed ID: 16618733
[TBL] [Abstract][Full Text] [Related]
11. Duffy antigen facilitates movement of chemokine across the endothelium in vitro and promotes neutrophil transmigration in vitro and in vivo.
Lee JS; Frevert CW; Wurfel MM; Peiper SC; Wong VA; Ballman KK; Ruzinski JT; Rhim JS; Martin TR; Goodman RB
J Immunol; 2003 May; 170(10):5244-51. PubMed ID: 12734373
[TBL] [Abstract][Full Text] [Related]
12. Growth regulated oncogene-alpha expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism.
Loukinova E; Dong G; Enamorado-Ayalya I; Thomas GR; Chen Z; Schreiber H; Van Waes C
Oncogene; 2000 Jul; 19(31):3477-86. PubMed ID: 10918606
[TBL] [Abstract][Full Text] [Related]
13. Combinatorial model of chemokine involvement in glomerular monocyte recruitment: role of CXC chemokine receptor 2 in infiltration during nephrotoxic nephritis.
Zernecke A; Weber KS; Erwig LP; Kluth DC; Schröppel B; Rees AJ; Weber C
J Immunol; 2001 May; 166(9):5755-62. PubMed ID: 11313419
[TBL] [Abstract][Full Text] [Related]
14. A growth-related oncogene/CXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer.
Wang B; Hendricks DT; Wamunyokoli F; Parker MI
Cancer Res; 2006 Mar; 66(6):3071-7. PubMed ID: 16540656
[TBL] [Abstract][Full Text] [Related]
15. Expression of angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 is highly responsive to ambient glutamine availability: role of nuclear factor-kappaB and activating protein-1.
Bobrovnikova-Marjon EV; Marjon PL; Barbash O; Vander Jagt DL; Abcouwer SF
Cancer Res; 2004 Jul; 64(14):4858-69. PubMed ID: 15256456
[TBL] [Abstract][Full Text] [Related]
16. The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity.
Addison CL; Daniel TO; Burdick MD; Liu H; Ehlert JE; Xue YY; Buechi L; Walz A; Richmond A; Strieter RM
J Immunol; 2000 Nov; 165(9):5269-77. PubMed ID: 11046061
[TBL] [Abstract][Full Text] [Related]
17. ELR+ CXC chemokine expression in benign and malignant colorectal conditions.
Rubie C; Frick VO; Wagner M; Schuld J; Gräber S; Brittner B; Bohle RM; Schilling MK
BMC Cancer; 2008 Jun; 8():178. PubMed ID: 18578857
[TBL] [Abstract][Full Text] [Related]
18. CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-κB pathway in colorectal cancer.
Chen C; Xu ZQ; Zong YP; Ou BC; Shen XH; Feng H; Zheng MH; Zhao JK; Lu AG
Cell Death Dis; 2019 Feb; 10(3):178. PubMed ID: 30792394
[TBL] [Abstract][Full Text] [Related]
19. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
20. METTL3 Inhibits Antitumor Immunity by Targeting m
Chen H; Pan Y; Zhou Q; Liang C; Wong CC; Zhou Y; Huang D; Liu W; Zhai J; Gou H; Su H; Zhang X; Xu H; Wang Y; Kang W; Kei Wu WK; Yu J
Gastroenterology; 2022 Oct; 163(4):891-907. PubMed ID: 35700773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
